Published on 26 Apr 2022 on Seeking Alpha
Celularity: Funds Infusion Needed ASAP To Advance (NASDAQ:CELU)
Celularity posted diluted EPS of -$1.49 for FY2021. The Company received 5 FDA fast...
NASDAQ.SRNE price evolution
NASDAQ.ONCT price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free